At A Glance
1
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases.
2
Revenue is primarily driven by Product (31.4%) and Scilex Pharmaceuticals Inc Product Sales (29.1%).
3
No significant events in the past 90 days.
—
Market Cap
—
Revenue
—
Net Income
Employees949
Fundamentals
How The Business Makes Money
Revenue by Segment
Product31.4%($100M)
Scilex Pharmaceuticals Inc Product Sales29.1%($93M)
Service17.3%($55M)
Service Customized Reagents10%($32M)
Other Service Revenue4.9%($16M)
Service Drug And Reagants4%($13M)
Sorrento Therapeutics Inc Product Revenues2.3%($7M)
Defense Advanced Research Projects Agency1%($3M)
Activity
What Changed Recently
No significant events in the past 90 days.
Analyst View
Company Profile
CIK0000850261
ISINUS83587F2020
CUSIP83587F202
Phone858 203 4100
Address4955 Directors Place, San Diego, CA, 92121, US
SEC EDGAR